Recent Posts
- Published in Health Affairs: Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs
- Policy Brief: The Share of Health Care Spending Growth Attributable to Rx
- Policy Brief: The Impact on Patient Health of Most-Favored-Nation Pricing of Already Marketed Drugs
- Rethinking What We Know About U.S. Drug Prices
- Drugs Are Cheaper Here Than Abroad, and Other Countries Should Adopt Our Model